Orbis has outgrown its part time jumpstart team and requires a full-time commercial team.  Orbis is currently recruiting for an experienced high-growth CEO, Chief Operations Officer, and an Immunologist. CEO – Orbis’ technology has developed successfully and it now seeks a full time CEO to focus on global commercialisation. The position requires experience in introducing…

Read More

About us: Pacific Channel invests in smart people solving hard problems to create a better future. We aim to provide capital, capability and connections to NZ-based ‘deep-tech’ companies based on breakthrough science and advanced engineering innovation. Through this support, we seek to create significant value and thereby impact for New Zealand, our stakeholders and all…

Read More

    Orbis Diagnostics, an Auckland-based Pacific Channel portfolio company developing an immunity test for Covid-19, has just signed a significant partnership with French multinational IDEMIA. Orbis’ test is not for the virus itself, but to assess whether an individual has developed effective immunity due to natural exposure to the virus or through a vaccine.…

Read More

Pacific Channel will invest the fund into deep-tech ventures built around breakthrough technology, solving worthwhile problems and creating meaningful global impact and value. The fund will invest into around 25 kiwi-based deep-tech companies developing clean-tech, agri-tech, future foods, advanced engineering and manufacturing innovation. The fund brings together several private investors as well as New Zealand…

Read More

Vortex Power Systems – a spin out from the University of Auckland’s Wind Engineering lab, is developing a novel method of generating electricity from wasted heat, has achieved a key milestone in validating its technology. Vortex’s technology utilises the wasted heat (in the form of water vapour) to fuel a man-made atmospheric buoyancy vortex. The…

Read More

InsituGen is developing a novel test which we believe will revolutionise steroid testing. The test can measure the anabolic effect of steroid use, meaning it enables detection of previously uncharacterised substances used to enhance performance. The past decade has seen numerous drug cheating scandals in international sports. Sport wants to provide a level playing field,…

Read More

COVID-19 has significantly impacted our ability to move about safely – within our own communities, countries and internationally.  The social and economic implications of this continue to be devastating. While people want assurance that life will return to normal, there is no clear end in sight. Currently, widespread vaccination is our main hope of returning to normality.…

Read More

We are proud to announce that $45m has now been committed to Pacific Channel Fund II; an NZ$50m early-stage investment fund focused on science and advanced engineering ‘deep-tech’ companies in New Zealand. The $45m includes a NZ$20m commitment from Elevate NZ Venture Fund; a NZ$300m fund of funds managed by NZ Capital Growth Partners, which was established by the Guardians…

Read More

Pacific Channel has released its updated internal analysis of Living Cell Technologies (ASX:LCT). LCT is an Australasian biotechnology company that is focused on developing a cell-based therapy for Parkinson’s Disease. The company announced on 23 July 2019 the outcome of its analysis work of the 2-year data, which showed a successful outcome of the Phase…

Read More